In this prospective cohort, there was a significantly increased risk of developing cardiovascular disease (CVD) in the ...

Imfinzi reduced risk of death by 27% and reduced disease progression by 24% compared to patients receiving a placebo. 2. In ...

Investigating the effects of home-based rehabilitation after intensive inpatient rehabilitation on motor function, activities ...

High volume-rate echocardiography for simultaneous imaging of electromechanical activation and cardiac strain of the whole heart in a single heartbeat in humans 1. Non-invasive high volume-rate ...

Tumor Treating Fields therapy demonstrates increased overall survival in patients with unresectable pancreatic cancer. The ...

1. The large language model, ChatGPT-4, answered 85.0% of examination-style multiple-choice questions on medical oncology correctly, a performance superior to all other large language models and ...

1. In this meta-analysis of randomized trials involving patients hospitalized with COVID-19, therapeutic-dose anticoagulation was found to be associated with a lower 28-day mortality risk compared ...

1. Local progression-free survival at 3 years was 84.3% in the SBRT group vs 67.3% in the RFA group, with HR 0.45 (significant). 2. HR for progression-free survival (HR 0.76) and overall survival (HR ...

Adult clinical trials found that Tremfya could treat plaque psoriasis by 16 weeks. Follow-up analysis found that roughly 23% of patients remained plaque free for more than 156 weeks. Tremfya is a ...

Study Rundown: Many patients with localized, high-risk soft tissue sarcomas develop metastatic disease. Immunotherapy, such as pembrolizumab, has shown potential when combined with conventional ...

Study Rundown: Breast cancer is the most common malignancy affecting female adults. TNBC, characterized by the lack of the expression of estrogen, progesterone, and human epidermal growth factor (HER2 ...

1. In this observational cohort study of patients with systemic lupus erythematosus, the current use of hydroxychloroquine as a treatment was associated with a decreased risk of cardiovascular events.